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The high level of intrat�moral hypoxia is one of the 
most characteristic feat�res of malignant tiss�e. This 
phenomenon is the most important in differences 
between t�mor and normal tiss�es as well as benign 
t�mors [���]. The investigation res�lts both experi-
mental and clinical st�dies has allowed on considering 
t�mor hypoxia as a powerf�l factor for angiogenesis 
ind�ction [4] facilitating t�mor progression and meta-
static spread [5� 6].
Pancreatic cancer is a near fatal disease with very 
�nfavorable clinical o�tcome despite the application of 
different treatment regimes [7]. One of the major ca�ses 
of therapy fail�re of pancreatic cancer is its systemic 
dissemination and extraordinary local t�mor progres-
sion� in partic�lar invasion into the adjacent tiss�es. It is 
remarkable that pancreatic cancer feat�red by high ag-
gressiveness is characterized by high level of hypoxia. 
Koong et al. [�] have provided the direct evidence d�e to 
pO� meas�rements �sing polarographic electrode that 
significant t�mor hypoxia exists in h�man pancreatic 
cancer. Several st�dies shown that pancreatic cancer 
hypoxia is associated with its aggressiveness and 
positively impact on malignant progression� incl�ding 
metastasis and chemoresistance [�� ��].
It is well known that extracell�lar proteases have 
been closely associated with metastatic phenotype of 
t�mor cells. There are rather clear evidences of a direct 
correlation between elevated level of t�mor matrix 
metalloproteinases �MMPs� activity and ability of t�mor 
to invade and metastasize [��� ��]. In o�r previo�s ex-
periments it was shown the direct correlation between 
MMPs activity and hypoxia level in primary t�mor that 
was accompanied with active metastasi zing in l�ng of 
t�mor-bearing animals [��]. The res�lts obtained have 
allowed �s to s�ppose that hypoxia affects positively 
MMPs activity in t�mor tiss�e res�lting in the enhance-
ment of metastasis.
Recently� the attention of scientists has been fo-
c�sed on the relatively new class of proteases� namely 
ADAMs �A Desintegrin And Metalloprotease domen� 
that are considered as a new factors associated with 
the invasiveness of the malignant t�mors. They are the 
members of a family of transmembrane proteins� which 
implicated in cell-cell interaction� proteolysis of mem-
brane proteins� and vario�s aspects of carcinogene-
sis [�4]. ADAM� is processed by a�tocatalysis into 
two forms: one is derived by removal of a prodomain 
�processed form� and the other is a remnant protein 
composed of the extracell�lar region� with a disintegrin 
domain at the amino termin�s [�5].
It was shown that some ADAMs are overexpressed 
in malignant t�mors and may be exploited as prognos-
tic markers [�6���]. The overexpression of ADAM�� 
ADAM�5 and ADAM�7 was observed in pancreatic can-
cer [�����]. The special interest is concentrated on 
АDАМ�� beca�se it is not inhibited by tiss�e inhibitors 
of metalloproteinases �TIMPs� and is different from 
other proteolytic proteins [��]. Correlation between 
АDАМ� expression and malignant progression as well 
as worse prognosis were observed in l�ng cancer� 
prostate carcinoma� kidney cancer and glioblastoma 
[�6���]. ADAM� overexpression in h�man pancreatic 
cancer was shown in o�r previo�s st�dy [�4].
At the same time the possible correlation between 
t�mor hypoxia and ADAMs expression was not f�lly 
investigated till now. This st�dy was aimed to eval�ate 
the effect of hypoxia on ADAM� expression in cell lines 
of h�man pancreatic cancer. 
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MATERIALS AND METHODS
Cell lines. ASPC-�� Panc-�� BxPC-�� Capan-� 
and MiaPaCa-� cell lines were obtained from Ameri-
can Type C�lt�re Collection �Rockville� MD� USA�. 
Colo-�57� S��6�6 and T�M4 cell lines were a gift from 
R.S. Metzgar �D�ke University� D�rham� NC� USA�. 
Cells were grown in RPMI-�64� medi�m s�pplemented 
with ��% FBS� ��� U/ml penicillin and ��� µg/ml strep-
tomycin �Invitrogen� Karlsr�he� Germany� and were 
inc�bated in a 5% CO� h�midified atmosphere.
Real-time quantitative polymerase chain reac-
tion (qRT-PCR). All reagents and eq�ipment for mRNA/
cDNA preparation were s�pplied by Roche Applied Sci-
ence �Mannheim� Germany�. mRNA of h�man pancreatic 
cell lines was prepared by a�tomated isolation �sing the 
MagNA p�re LC instr�ment and isolation kit I �for cells� 
and kit II �for tiss�es�. cDNA was prepared �sing the first-
strand cDNA synthesis kit for RT-PCR �AMV� according to 
the man�fact�rer’s instr�ctions. The primer seq�ences 
for ADAM� were obtained from Search-LC �Heidelberg� 
Germany�. Real-time PCR was performed �sing the 
LightCycler FastStart DNA SYBR Green kit. The n�mber 
of specific transcripts was normalized to the average 
expression of two ho�sekeeping genes �cyclophilin B and 
HPRT� and presented as adj�sted transcripts/µl cDNA� 
as described previo�sly [�5].
Immunoblot analysis. Cells were lysed in a lysis 
b�ffer containing 5� mM Tris-HCl pH 7.5� �5� mM 
NaCl� �mM EDTA pH �.�� and the Complete Protease 
Inhibitor Cocktail Tablet �Roche Diagnostics GmbH� 
Mannheim� Germany� and �% SDS. �7��5 µg proteins 
were separated on N�PAGE Novex Bis-Tris 4���% 
gels �Invitrogen� Karlsr�he� Germany� and electro-
blotted onto nitrocell�lose membranes. Membranes 
were then inc�bated in blocking sol�tion �5% milk in 
�� mM Tris HCl� �5� mM NCl� �.�% Tween-���� fol-
lowed by overnight inc�bation with a rabbit polyclonal 
ADAM� antibody �dil�tion � : �5� in blocking sol�tion� 
�Chemicon International� Temec�la� CA� USA�. The 
membranes were then washed in TBS-T and inc�bated 
with anti-rabbit horseradish peroxidase-conj�gated 
secondary antibodies �Amersham Bioscience� B�ck-
inghamshire� UK�. Antibody detection was performed 
with an enhanced chemil�minescence reaction �ECL� 
Amersham Bioscience�. Eq�al loading and transfer 
was confirmed �sing γ-t�b�lin and ERK-� antibodies 
�Santa Cr�z Biotechnology� Inc.� Santa Cr�z� CA� USA�. 
For semiq�antitative analysis of the imm�noblots� 
densitometry was carried o�t and the signal intensity of 
ADAM� expression was normalized to its correspond-
ing signal intensity of γ-t�b�lin.
Hypoxia treatment. Cells were grown to ∼ 7�% 
confl�ence in �� cm tiss�e c�lt�re dishes. For hypoxia 
treatment� cells were inc�bated in a hypoxic chamber 
with fresh complete medi�m �Bill�ps-Rothenberg� Inc.� 
Del Mar� CA� USA� with an ��.�5%/��%/�.75% mix-
t�re of N�/CO�/O� for �4 h. After the indicated time of 
hypoxia expos�re� RNA and proteins were extracted 
from hypoxic and normoxic pancreatic cancer cells as 
described above.
Statistical analysis. Res�lts are expressed as a 
mean ± SEM. Statistical analysis was performed �sing 
non-parametric Mann — Whitney test.
RESULTS
QRT-PCR was performed to eval�ate the expres-
sion of ADAM� mRNA in pancreatic cancer cell lines 
affected by hypoxia compared to normal condition of 
these cell lines. Therefore� different amo�nts of ADAM� 
mRNA within a range of �6���� copies/µl cDNA were 
detected in all examined pancreatic cancer cell lines 
�nder normoxia �Table ��. Then� the effects of hypoxia 
on ADAM� mRNA levels were examined in pancreatic 
cancer cells. Hypoxia ind�ced an increase of ADAM� 
mRNA levels of �.5�5.�-fold in all examined pancreatic 
cancer cell lines except Panc-� with the lowest basal 
level of ADAM� mRNA �Table ��. BxPC-�� Capan-� 
and S��6�6 have shown the highest relative increase 
of ADAM� mRNA expression levels �nder the effects 
of hypoxia. The clear tendency to increase levels of 
ADAM� mRNA �nder hypoxia condition as compared 
to normoxia ones was observed. 
Table 1. ADAM8 mRNA expression in pancreatic cancer cells exposed to 
hypoxia
Cell lines Culture conditions
Copies/µl cDNA 
(mean ± SEM)
Hypoxia/normoxia ratio of 
mRNA expression
Aspc-1 Normoxia 847.0 ± 427.9
Hypoxia 2246.0 ± 954.2 2.6
BxPC-3 Normoxia 140.5 ± 7.5
Hypoxia 470.0 ± 275.0 3.3
Capan-1 Normoxia 439.7 ± 180.3
Hypoxia 1612.0 ± 215.4 3.7
Colo-357 Normoxia 42.0 ± 11.0
Hypoxia 104.5 ± 20.5 2.5
MiaPaCa-2 Normoxia 52.5 ± 15.5
Hypoxia 136.0 ± 8.0 2.6
Panc-1 Normoxia 15.5 ± 7.5
Hypoxia 19.0 ± 4.0 1.2
Su-8686 Normoxia 740.5 ± 287.5
Hypoxia 4356.0 ± 1301.0 5.9
T3M4 Normoxia 929.0 ± 215.0
Hypoxia 2419.0 ± 834.5 2.6
Imm�noblot analysis was performed to compare 
the mRNA data with the corresponding protein expres-
sion level. It has been shown that ADAM� was present 
in two forms �6� kDa and �� kDa� in the all investi-
gated cell lines altho�gh the basal level of expression 
was different being in parallel with the expression of 
mRNA �Fig�re�. The �� kDa processed form contains 
the metalloprotease �MP� domain responsible for the 
proteolytic activity of ADAM�� and the 6� kDa remnant 
form mediates cell adhesion [�5]. On the protein level� 
hypoxia ind�ced a �.��5.�-fold increase of the ADAM� 
prodomain removal form ��� kDa� in 5/� pancreatic 
cancer cells. In Panc-� cells� there was a �.4-fold 
decrease of ADAM� in response to hypoxia� and in 
BxPC-� and S��6�6 there were no significant changes 
observed �Table ��. Additionally� hypoxia ind�ced a 
�.���.�-fold increase of the remnant form ADAM� 
�6� kDa� in 4/� pancreatic cancer cell lines: Aspc-�� 
Colo-�57� Panc-�� T�M4 �see Table ��. From these 
res�lts we might concl�de� that in some pancreatic 
cancer cell lines tendency to increase levels of ADAM� 
protein �nder effect of hypoxia was observed.
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Figure. ADAM� protein expression in pancreatic cancer cell lines 
was determined by imm�noblotting. Eq�al loading of the protein 
samples was confirmed �sing γ-t�b�lin antibody. Size markers 
are indicated on the left �in kDa�
Table 2. ADAM8 protein expression in pancreatic cancer cells exposed 
to hypoxia
Cell lines Hypoxia/normoxia ratio of ADAM8 forms protein expression90 kDa 60 kDa
Aspc-1 1.9 1.96
BxPC-3 1.04 0.94 ↓
Capan-1 1.22 1.07
Colo-357 5.91 1.46
MiaPaCa-2 1.73 0.78 ↓
Panc-1 0.41 ↓ 1.33
Su-8686 1.09 1.02
T3M4 1.48 1.35
DISCUSSION
ADAMs are a large family of transmembrane pro-
teins that are involved in proteolysis� making them 
candidates for mediating the remodeling of the ex-
tracell�lar matrix �ECM�. ADAMs affects cell adhesion 
and cell migration� which is important �nder physio-
logical conditions. D�ring t�mor development these 
effects might infl�ence the ability of cancer cells to 
metastasize� making these proteins possible targets 
for anti-t�mor therapy [�6]. ADAM�� one of the mem-
bers of the ADAM family� is overexpressed in vario�s 
h�man t�mors [�6���]. It has been shown previo�sly 
that hypoxia infl�ences the expression of some ADAM 
proteins [�7� ��]. Namely� oxidative stress ind�ced 
ADAM� protein expression in h�man prostate cancer 
cells and chronic hypoxia red�ce expression ADAM�� 
and TACE proteins in the h�man ne�roblastoma b�t 
witho�t altering their mRNA levels [�7� ��]. 
In o�r st�dy ADAM� mRNA expression has been 
shown to increase in all pancreatic cancer cell lines 
�nder hypoxic conditions altho�gh ADAM� protein 
expression increased in 5 of � pancreatic cancer cell 
lines �nder hypoxic condition. Interesting� BxPc-� and 
S��6�6 cell lines have not shown changes of ADAM� 
protein expression �one of the two presented active 
forms� �nder hypoxia. It was shown the decrease of 
ADAM� protein expression ��� kDa form only� �nder 
hypoxia in Panc-� cell line. �� kDa processed form 
contains metalloprotease domain responsible for 
proteolytic activity of ADAM� and is a potential shed-
ding protein. 6� kDa form of ADAM� protein mediates 
cell adhesion. It was also shown increase of ADAM� 
�� kDa form expression in MiaPaCa-� cell line that 
might indicate the increase of shedding ability of ADAM� 
protein �nder hypoxia in this cell line. It was observed 
the increase of both forms of ADAM� protein expres-
sion �nder hypoxia in T�M4 cell line at the same level. 
Colo-�57 cell line was characterised by the highest 
increase of level of ADAM� �� kDa form expression 
�nder hypoxia compared to normoxia condition of this 
cell line c�ltivation. As we known� BxPc-� Panc-� and 
MiaPaCa-� cell lines originated from primary t�mor 
of pancreatic carcinoma �G��� Aspc-�-ascites �G��� 
S��6�6� Capan-�-liver metastasis �S��6�6-G�/�� 
Capan-�-G�� and T�M4-lymph metastasis �G��. It is 
needed to remark that observed changes in expression 
of ADAM�mRNA and ADAM� protein were registered 
in cells exposed in vitro to hypoxia d�ring �4 h. At the 
same time� t�mor tiss�e in vivo is characterized by the 
contin�o�s expos�re of t�mor cells to chronic hypoxia 
res�lting in the rearrangement of molec�lar profile of 
t�mor. This fact may partly explain why increase of both 
mRNA and protein ADAM� expression was not s�bstan-
tial �nder relatively short-term exposition to hypoxia. 
In the previo�s work it has been shown that ADAM� 
protein presents in the normal pancreatic tiss�es in one 
active form only �6� kDa form remnant protein which 
is a potential adhesion molec�le�. In comparison to 
this fact� ADAM� protein fo�nd to be expressed in two 
active forms: potential shedding protein and remnant 
protein in the pancreatic tiss�es �nder chronic pan-
creatitis and pancreatic cancer [�4].
Th�s� in the present st�dy we observed the tendency 
of increasing both ADAM� mRNA and ADAM� protein 
levels in pancreatic cancer cell lines �nder hypoxia com-
pared to normal conditions of oxygenation. A potential 
role of ADAM� as a hypoxia-dependent protein in the 
pathogenesis and evol�tion of pancreatic cancer that is 
characterized by high level of intrat�moral hypoxia may 
be s�ggested. Pancreatic cancer cell lines with different 
levels of ADAM� expression �nder hypoxia compared to 
normoxia may be exploited for screening of new antican-
cer s�bstances� in partic�lar hypoxia-dependent.
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ЗАВИСИМАЯ ОТ ГИПОКСИИ ЭКСПРЕССИЯ БЕЛКА ADAM8 
В КЛЕТОЧНЫХ ЛИНИЯХ РАКА ПОДЖЕЛУДОЧНОЙ ЖЕЛЕЗЫ 
ЧЕЛОВЕКА
Введение: известно, что характерной чертой злокачественных опухолей является внутриопухолевая гипоксия, положительно 
влияющая на злокачественную прогрессию. Рак поджелудочной железы (РПЖ) является очень агрессивной опухолью, 
обладающей высокой способностью к инвазии в близлежащие ткани и органы, что обусловливает неудовлетворительные 
результаты лечения. Показано при этом, что РПЖ относится к новообразованиям с высокой степенью гипоксии. Цель: 
установление возможной зависимости экспрессии белка АДАМ8 и его мРНК от уровня оксигенации клеток. Материалы 
и методы: использовали клеточные линии РПЖ человека. Экспрессию мРНК и белка ADAM8 определяли методами qRT­
PCR и вестерн­блот­анализа соответственно. Результаты: установлено, что гипоксия индуцировала повышение уровня 
мРНК АDAM8 в 2,5–5,9 раза в исследованных клеточных линиях РПЖ, за исключением клеток линии Panc­1. В клетках 
линий BxPC­3, Capan­1 и Su8686 выявлено наиболее значительное возрастание уровня экспрессии мРНК ADAM8 при 
гипоксии (p = 0,046). С помощью вестерн­блот­анализа показано, что экспрессия удаляемой формы продомена ADAM8 
(90 kDa) усиливалась в несколько раз при гипоксии в 5 из 8 изученных клеточных линий РПЖ. Гипоксия индуцировала 
повышение экспрессии остаточной формы ADAM8 (60 kDa) в 4 из 8 клеточных линий РПЖ: Aspc­1, Colo­357, Panc­1, 
T3M4, хотя изменения оказались умеренно выраженными. Выводы: в клеточных линиях РПЖ человека отмечается четкая 
тенденция к повышению при гипоксии уровня экспрессии, как мРНК, так и белка ADAM8, что позволяет предположить 
зависимость экспрессии от уровня оксигенации и потенциальную роль ADAM8 в развитии и прогрессии РПЖ, который 
отличается высокой степенью внутриопухолевой гипоксии.
Ключевые слова: рак поджелудочной железы, инвазия, ADAM8, гипоксия.
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